Weight Loss Drugs: Bone & Muscle Risks episode artwork

EPISODE · Dec 26, 2024 · 13 MIN

Weight Loss Drugs: Bone & Muscle Risks

from NEWSNUGGET

Weight loss drugs, like semaglutide and tirzepatide, based on gut hormones, are effective but may cause significant loss of muscle and bone mass, impacting long-term health. This loss stems from increased muscle protein breakdown and reduced bone stress. To mitigate these risks, individuals should increase protein intake, engage in resistance training, and maintain regular physical activity. While the long-term effects are still being studied, combining medication with lifestyle changes is currently the best approach.keepSave to notecopy_alldocsAdd noteaudio_magic_eraserAudio OverviewschoolBriefing doc

Episode metadata supplied by the publisher feed · Published Dec 26, 2024

Embed this episode

Ready to play

Weight Loss Drugs: Bone & Muscle Risks

0:00 13:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of NEWSNUGGET?

This episode is 13 minutes long.

When was this NEWSNUGGET episode published?

This episode was published on December 26, 2024.

Can I download this NEWSNUGGET episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!